One of the highlights of Day 1 of #ISSCR2018 for me so far was the talk by Lorenz Studer (Co-Founder of BlueRock) on the use of human embryonic stem cell (HESC)-derived dopamine neurons for Parkinson’s Disease. Note that for this […]

The post Lorenz Studer on Day 1 #ISSCR2018: HESC-based therapies for Parkinson’s Disease appeared first on The Niche.